PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Nasal Cavity and Paranasal Sinuses Cancer
A risk factor is anything that increases your chances of getting a disease like cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed.
But risk factors don’t tell us everything. Having a risk factor, or even several, does not mean that you will get the disease. Many people with risk factors never develop these cancers, while people with these cancers may have few or no known risk factors.
Researchers have found a few risk factors that make a person more likely to develop nasal cavity (nose) and paranasal sinus cancer. Most of these are exposures to inhaled substances in the workplace.Other risk factors are similar to those for other cancers in the head and neck area, such as smoking.
People who work in certain jobs are more likely to develop nasal cavity and paranasal sinus cancers. The increased risk seems to be related to breathing in certain substances while at work, such as:
These workplace exposures have less clear links to nasal and paranasal sinus cancer:
Smoking increases the risk of nasal cavity cancer, specifically the squamous cell type.
The human papillomavirus (HPV) is a group of over 200 related viruses. They are called papilloma viruses because some of them cause a type of benign (not cancer) growth called a papilloma, more commonly known as a wart.
But infection with certain high-risk types of HPV can cause some forms of cancers, including cancers of the cervix, vagina, anus, vulva, penis, mouth, and throat. HPV has been found in some cancers of the nasal cavity and paranasal sinuses, but because these cancers are rare, more research is needed to show that HPV infection causes them.
Cancers of the nasal cavity and paranasal sinuses are about 2 times more common in men than women.
About 80% (8 out of 10 people) of people diagnosed with cancer of the nasal cavity or paranasal sinus are older than 55 years of age.
Cancers of the nasal cavity and paranasal sinuses are much more common among White people than Black people.
People with the hereditary form of retinoblastoma, a type of eye cancer that typically develops in children, have an increased risk of nasal cavity cancer if the retinoblastoma was treated with radiation.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Banuchi V, Mallen J, Kraus D. Cancers of the nose, sinus, and skull base. Surg Oncol Clin N Am. 2015;24(3):563-577.
Bossi P, Farina D, Gatta G, et al. Paranasal sinus cancer. Crit Rev Oncol Hematol. 2016;98:45-61.
Castellsagué X, Alemany L, Quer M, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016;108(6):djv403. Published 2016 Jan 28. doi:10.1093/jnci/djv403.
Dutta R, Dubal PM, Svider PF, Liu JK, Baredes S, Eloy JA. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival. Laryngoscope. 2015;125(11):2491-2497. doi:10.1002/lary.25465.
Kılıç S, Kılıç SS, Kim ES, et al. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2017;7(10):980-989.
Leeman JE, Katabi N, Wong, RJ, Lee NY, Romesser PB. Chapter 65 - Cancer of the Head and Neck. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst. 2008;100:1771–1779.
Mendenhall WM, Dziegielewski PT, and Pfister DG. Chapter 45- Cancer of the Head and Neck. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2019.
National Cancer Institute. Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ)–Patient Version. November 06, 2016. Accessed at www.cancer.gov/types/head-and-neck/patient/paranasal-sinus-treatment-pdq on November 10, 2020.
Sanghvi S, Khan MN, Patel NR, Yeldandi S, Baredes S, Eloy JA. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope. 2014;124(1):76-83. doi:10.1002/lary.24264.
Thompson LDR, Franchi A. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base. Virchows Arch. 2018;472(3):315-330. doi:10.1007/s00428-017-2116-0.
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877-885. doi:10.1002/hed.21830.
Youlden DR, Cramb SM, Peters S, et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013;37(6):770-779. doi:10.1016/j.canep.2013.09.014.
Last Revised: April 19, 2021
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.